Upload Avatar (500 x 500)
Xuetao Cao
Chinese, English
Beijing
Peking Union Medical College
Basic Medical Sciences
  • Academician of the Chinese Academy of Engineering
  • Foreign Academician of the German Academy of Sciences
  • Foreign Academician of the French Academy of Medical Sciences
  • Foreign Academician of the British Academy of Medical Sciences
  • Published over 230 SCI papers as corresponding author
  • President of the Chinese Academy of Medical Sciences
  • President of Peking Union Medical College
  • Chairman of the Chinese Society of Biomedical Engineering
  • Chairman of the Life Sciences Union of the Chinese Association for Science and Technology
  • Secretary-General of the Asia-Pacific Immunology Association
  • National Natural Science Second Prize (2003)
  • First Prize of Chinese Medical Science and Technology Award
  • First Prize of Military and Shanghai Science and Technology Progress Award
  • First Prize of Shanghai Natural Science Award
  • Guanghua Engineering Award of the Chinese Academy of Engineering (2012)
  • Chen Jiageng Life Science Award of the Chinese Academy of Sciences (2016)
  • China Youth Science and Technology Award
Innate Immunity and Inflammation
Tumor Immunotherapy
  • The RNA helicase DDX46 inhibits innate immunity by entrapping m6A-demethylated antiviral transcripts in the nucleus., Zheng Q, Hou J, Zhou Y, Li Z, Cao X., 2017
  • Methyltransferase SETD2-mediated methylation of STAT1 is critical for interferon antiviral activity., Chen K, Liu J, Liu S, Xia M, Zhang X, Han D, Jiang Y, Wang C, Cao X., 2017
  • Tumor Exosomal RNAs promote lung pre-metastatic niche formation by activating alveolar epithelial TLR3 to recruit neutrophils., Liu Y, Gu Y, Han Y, Zhang Q, Jiang Z, Zhang X, Huang B, Xu X, Zheng J, Cao X., 2016
  • The lectin Siglec-G inhibits dendritic cell cross-presentation by impairing MHC class I-peptide complex formation., Ding Y, Guo Z, Liu Y, Li X, Zhang Q, Xu X, Gu Y, Zhang Y, Zhao D, Cao X., 2016
  • Methyltransferase Dnmt3a upregulates HDAC9 to deacetylate the kinase TBK1 for activation of antiviral innate immunity., Li X, Zhang Q, Ding Y, Liu Y, Zhao D, Zhao K, Shen Q, Liu X, Zhu X, Li N, Cheng Z, Fan G, Wang Q, Cao X., 2016
  • K33-linked polyubiquitination of Zap70 by Nrdp1 controls CD8+ T cell activation., Yang M, Chen T, Li X, Yu Z, Tang S, Wang C, Gu Y, Liu Y, Xu S, Li W, Zhang X, Wang J, Cao X., 2015
  • Tet2 is required to resolve inflammation by recruiting Hdac2 to specifically repress IL-6., Zhang Q, Zhao K, Shen Q, Han Y, Gu Y, Li X, Zhao D, Liu Y, Wang C, Zhang X, Su X, Liu J, Ge W, Levine RL, Li N, Cao X., 2015
  • Rhbdd3 controls autoimmunity by suppressing the production of IL-6 by dendritic cells via K27-linked ubiquitination of the regulator NEMO., Liu J, Han C, Xie B, Wu Y, Liu S, Chen K, Xia M, Zhang Y, Song L, Li Z, Zhang T, Ma F, Wang Q, Wang J, Deng K, Zhuang Y, Wu X, Yu Y, Xu T, Cao X., 2014
  • Small GTPase RBJ mediates nuclear entrapment of MEK1/MEK2 in tumor progression., Chen T, Yang M, Yu Z, Tang S, Wang C, Zhu X, Guo J, Li N, Zhang W, Hou J, Liu H, Han C, Liu Q, Gu Y, Qian C, Wan T, Cui L, Zhu M, Zheng W, Cao X., 2014
  • Hepatic RIG-I predicts survival and interferon-α therapeutic response in hepatocellular carcinoma., Hou J, Zhou Y, Zheng Y, Fan J, Zhou W, Ng IO, Sun H, Qin L, Qiu S, Lee JM, Lo CM, Man K, Yang Y, Yang Y, Yang Y, Zhang Q, Zhu X, Li N, Wang Z, Ding G, Zhuang SM, Zheng L, Luo X, Xie Y, Liang A, Wang Z, Zhang M, Xia Q, Liang T, Yu Y, Cao X., 2014
  • The STAT3-binding long noncoding RNA lnc-DC controls human dendritic cell differentiation., Wang P, Xue Y, Han Y, Lin L, Wu C, Xu S, Jiang Z, Xu J, Liu Q, Cao X., 2014
  • Induction of Siglec-G by RNA viruses inhibits the innate immune response by promoting RIG-I degradation., Chen W, Han C, Xie B, Hu X, Yu Q, Shi L, Wang Q, Li D, Wang J, Zheng P, Liu Y, Cao X., 2013
  • Histone Methyltransferase Ash1l Suppresses Interleukin-6 Production and Inflammatory Autoimmune Diseases by Inducing the Ubiquitin-Editing Enzyme A20., Xia M, Liu J, Wu X, Liu S, Li G, Han C, Song L, Li Z, Wang Q, Wang J, Xu T, Cao X., 2013
  • Constitutive MHC class I molecules negatively regulate TLR-triggered inflammatory responses via the Fps-SHP-2 pathway., Xu S, Liu X, Bao Y, Zhu X, Han C, Zhang P, Zhang X, Li W, Cao X., 2012
  • Intracellular MHC class II molecules promote TLR-triggered innate immune responses by maintaining Btk activation., Liu X, Zhan Z, Li D, Xu L, Ma F, Zhang P, Yao H, Cao X., 2011
  • The microRNA miR-29 controls innate and adaptive immune responses to intracellular bacterial infection by targeting interferon-γ., Ma F, Xu S, Liu X, Zhang Q, Xu X, Liu M, Hua M, Li N, Yao H, Cao X., 2011
  • Identification of miRNomes in human liver and hepatocellular carcinoma reveals miR-199a/b-3p as a therapeutic target for hepatocellular carcinoma., Hou J, Lin L, Zhou W, Wang Z, Ding G, Dong Q, Qin L, Wu X, Zheng Y, Yang Y, Tian W, Zhang Q, Wang C, Zhang Q, Zhuang S, Zheng L, Liang A, Tao W, and Cao X., 2011
  • The cytosolic nucleic acid sensor LRRFIP1 mediates the production of type I interferon via a beta-catenin-dependent pathway., Yang P, An H, Liu X, Wen M, Zheng Y, Rui Y, Cao X., 2010
  • Integrin CD11b negatively regulates TLR-triggered inflammatory response by activating Syk and promoting MyD88 and TRIF degradation via cbl-b., Han C, Jin J, Xu S, Liu H, Li N, Cao X., 2010
  • The E3 ubiquitin ligase Nrdp1 preferentially promotes TLR-mediated type I interferon production., Wang C, Chen T, Zhang J, Yang M, Li N, Xu X, Cao X., 2009
  • Phosphatase SHP-1 promotes TLR- and RIG-I-activated production of type I interferon by inhibiting kinase IRAK-1., An H, Hou J, Zhou J, Zhao Y, Xu H, Zheng Y, Yu Y, Liu S and Cao X., 2008
Immunity Inflammation Tumor Therapy Research Innate Immune Response Molecular Biomedical Innovation

Contact us

Let's talk!
* Required
* Required
* Required
* Invalid email address
By submitting this form, you agree that IoT ONE may contact you with insights and marketing messaging.
No thanks, I don't want to receive any marketing emails from IoT ONE.
Submit

Thank you for your message!
We will contact you soon.